REGENXBIO Inc. (RGNX)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 09:36AM EDT. Market open.
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 787.63M |
| Enterprise Value | 601.66M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.78 |
| Price/Book (mrq) | 2.53 |
| Enterprise Value/Revenue | 6.67 |
| Enterprise Value/EBITDA | -2.51 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.32 |
| 52-Week Change 3 | -17.05% |
| S&P500 52-Week Change 3 | 21.08% |
| 52 Week High 3 | 28.80 |
| 52 Week Low 3 | 11.83 |
| 50-Day Moving Average 3 | 19.83 |
| 200-Day Moving Average 3 | 17.81 |
Share Statistics
| Avg Vol (3 month) 3 | 753.96k |
| Avg Vol (10 day) 3 | 456.08k |
| Shares Outstanding 5 | 49.04M |
| Implied Shares Outstanding 6 | 49.04M |
| Float 8 | 37.36M |
| % Held by Insiders 1 | 7.18% |
| % Held by Institutions 1 | 81.91% |
| Shares Short (Apr 15, 2024) 4 | 4.07M |
| Short Ratio (Apr 15, 2024) 4 | 7.66 |
| Short % of Float (Apr 15, 2024) 4 | 10.87% |
| Short % of Shares Outstanding (Apr 15, 2024) 4 | 8.29% |
| Shares Short (prior month Mar 15, 2024) 4 | 4.15M |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | N/A |
| Last Split Date 3 | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -291.99% |
| Operating Margin (ttm) | -271.03% |
Management Effectiveness
| Return on Assets (ttm) | -23.49% |
| Return on Equity (ttm) | -63.65% |
Income Statement
| Revenue (ttm) | 90.24M |
| Revenue Per Share (ttm) | 2.06 |
| Quarterly Revenue Growth (yoy) | -29.10% |
| Gross Profit (ttm) | N/A |
| EBITDA | -247.11M |
| Net Income Avi to Common (ttm) | -263.49M |
| Diluted EPS (ttm) | -6.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 275.26M |
| Total Cash Per Share (mrq) | 6.2 |
| Total Debt (mrq) | 183.34M |
| Total Debt/Equity (mrq) | 58.81% |
| Current Ratio (mrq) | 2.57 |
| Book Value Per Share (mrq) | 7.08 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -218.41M |
| Levered Free Cash Flow (ttm) | -133.51M |
© 2024 Yahoo. All rights reserved.